Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 3 1

Status

Unknown 3Recruiting 3Terminated 1

Sponsor Class

OTHER_GOV 4OTHER 2INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 2Genitourinary 1Breast 1

Conditions

Ovarian Neoplasms 2Colorectal Neoplasms 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2384Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Etodolac × Clear all
NCT05429970 2026-05-18

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
35 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06839144 2025-07-11

OC-POP-PT

Tel-Aviv Sourasky Medical Center

Phase 2 Recruiting
60 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT03838029 2019-11-20

BC-PC

Assaf-Harofeh Medical Center

Phase 2 Unknown
210 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03919461 2019-04-18

COMPIT-2

Assaf-Harofeh Medical Center

Phase 2 Recruiting
200 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01857817 2018-04-26

Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer

Vicus Therapeutics

Phase 2 Terminated
35 enrolled
Genitourinary

Prostatic Neoplasms

NCT00502684 2014-07-01

Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery

Kaplan Medical Center

Phase NA Unknown
32 enrolled
Breast

Breast Neoplasms

NCT00888797 2011-07-12

β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence

Sheba Medical Center

Phase 3 Unknown
400 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡